Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
MedTech
Illumina previews updated tumor research assay, ships IVD kits
Version 2 of the TruSight Oncology 500 research-use-only assay is currently under development, the company said, with its release set for mid-2025.
Conor Hale
Nov 22, 2024 9:30am
Former FDA leader launches $70M biotech fund
Nov 19, 2024 12:45pm
FDA approves Caris multi-cancer companion diagnostic test
Nov 13, 2024 9:00am
Roche sparks $1.8B-plus discovery deal with Flare Therapeutics
Nov 12, 2024 7:00am
23andMe shutters cancer drug research, lays off 40% of staff
Nov 11, 2024 9:07pm
NYU Langone taps Philips to take its pathology digital
Oct 16, 2024 9:00am